• Skip to primary navigation
  • Skip to main content

PEPTIDES - LATEST HOT 🔥 INFO

Peptide News and Research

  • Home
  • Podcast
  • Hot 🔥 Articles
  • About Us
    • Who We Are
    • Privacy Policy
  • Partners

weightloss

How GLP-1 Agonists May Improve NASH

October 17, 2024 Dr. Nikki Leave a Comment

Have you heard of fatty liver disease? Well, fatty liver disease is just what it sounds like—it’s when fat builds up in the liver and starts causing issues. The official name for it is “nonalcoholic fatty liver disease,” or NAFLD for short. Now, if that fat buildup leads to inflammation, it’s called “nonalcoholic steatohepatitis,” or […]

Filed Under: Podcast Tagged With: glp1, peptides, semaglutide, weightloss

Switching From Semaglutide to Tirzepatide

October 10, 2024 Dr. Nikki Leave a Comment

Someone might switch from semaglutide to tirzepatide to achieve greater weight loss or improve blood sugar control. Tirzepatide has been shown to be more effective for some people because it works on two different hormones, GLP-1 and GIP. This combination can lead to better results in managing weight and overall health.  Additionally, if a person […]

Filed Under: Podcast Tagged With: peptides, semaglutide, tirzepatide, weightloss

Tirzepatide for the Treatment of Obstructive Sleep Apnea

October 3, 2024 Dr. Nikki Leave a Comment

Imagine waking up refreshed after a full night’s sleep, free from the constant interruptions of obstructive sleep apnea (OSA). Now, imagine treating your OSA without relying on a bulky CPAP machine but with a convenient once-weekly injectable medication instead. Enter tirzepatide, the breakthrough peptide originally designed for diabetes and weight loss, is now making waves […]

Filed Under: Podcast Tagged With: peptides, sleep, tirzepatide, weightloss

Differences Between Semaglutide and Tirzepatide

September 11, 2024 Dr. Nikki Leave a Comment

Two of the most promising treatments for obesity in recent years are semaglutide, a GLP-1 agonist, and tirzepatide, a dual GLP-1/GIP agonist. These peptides have garnered attention for their impressive efficacy in weight loss and metabolic improvement, but they differ in their mechanisms, dosing, side effects, and outcomes. In this podcast, we’ll explore how these […]

Filed Under: Podcast Tagged With: glp1, peptides, semaglutide, tirzepatide, weightloss

Debunking the Myth: “You Can’t Stop Taking GLP-1 Agonists”

July 31, 2024 Dr. Nikki Leave a Comment

One common misconception about GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Zepbound), is that once you start taking them, you can never stop. This myth can deter individuals from considering these highly effective medications for weight loss.  In this podcast, we’ll debunk this myth and provide a clearer understanding of how GLP-1 agonists can […]

Filed Under: Podcast Tagged With: peptides, semaglutide, weightloss

How Do GLP-1 Agonists Affect Metabolism?

July 8, 2024 Dr. Nikki Leave a Comment

What is Metabolism? Metabolism refers to the biochemical processes in which our bodies convert food and drink into energy. This energy is then used to fuel bodily functions such as breathing, circulating blood, and repairing cells.  Metabolism is divided into two categories: How Does Metabolism Maintain Weight? Our body weight is determined by the balance […]

Filed Under: Podcast Tagged With: peptides, semaglutide, weightloss

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Copyright © 2025

PEPTIDES

The contents of this website, such as text, graphics, images, and other material contained on the website (“Content”) are for informational purposes. Our site is not intended to be a substitute for professional medical advice, diagnosis, or treatment from a licensed healthcare professional. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

Never disregard professional medical advice or delay in seeking it because of something you have read on this website.